Correction to: An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis
Bone Marrow Transplant. 2022 May;57(5):852.
doi: 10.1038/s41409-022-01625-6.
1 Division of Transplantation and Cellular Therapy, University of Miami Miller School of Medicine, Miami, FL, USA. amjimenez@med.miami.edu.
2 Department of Medicine, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH, USA.
3 Division of Transplantation and Cellular Therapy, University of Miami Miller School of Medicine, Miami, FL, USA.
4 (CIBMTR)® Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
5 Division of Biostatistics, Institute for Health and Society, Medical College of Wisconsin, Milwaukee, WI, USA.
6 Division of Hematology, Oncology and Blood & Marrow Transplantation, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA, USA.
7 Divisions of Hematology/Oncology & Infectious Diseases, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
8 Department of Oncology, King Faisal Specialist Hospital Center & Research, Riyadh, Saudi Arabia.
9 Mayo Clinic Rochester, Rochester, MN, USA.
10 Columbia University Irving Medical Center, Department of Medicine, Bone Marrow Transplant and Cell Therapy Program, New York, NY, USA.
11 Department of Hematology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
12 CHU and University of Liege, Liege, Belgium.
13 Sarah Cannon Blood Cancer Network, Nashville, TN, USA.
14 Department of Blood & Marrow Transplant and Cellular Immunotherapy (BMT CI), Moffitt Cancer Center, Tampa, FL, USA.
15 The Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA.
16 Vanderbilt University Medical Center, Nashville, TN, USA.
17 Department of Hematology, CHU Grenoble Alpes, Université Grenoble Alpes, Grenoble, France.
18 Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Department of Pediatrics, New York Medical College, Valhalla, NY, USA.
19 UF Health Shands Children's Hospital, Gainesville, FL, USA.
20 Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
21 Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA, USA.
22 Department of Hematology/Oncology, Hospital Infantil Universitario Niño Jesus, Madrid, Spain.
23 Division of Hematology, Department of Medicine, Dalhousie University, Halifax, NS, Canada.
24 Haematology Research Centre, Department of Immunology and Inflammation, Imperial College London, London, UK.
25 Christian Medical College, Vellore, India.
26 Markey Cancer Center, University of Kentucky, Lexington, KY, USA.
27 Division of Hematology/BMT, Mayo Clinic, Rochester, MN, USA.
28 Experimental Transplantation and Immunotherapy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
29 UT Southwestern Medical Center, Blood and Marrow Transplant Program, Dallas, TX, USA.
30 Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, USA.
31 Department of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA.
32 Markey Cancer Center, University of Kentucky College of Medicine, Lexington, KY, USA.
33 Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA.
34 Divison of Clinical Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
35 Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center, Minneapolis, MN, USA.
36 Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, Toronto, ON, Canada.
37 Azienda Ospedaliera Universitaria Policlinico-San Marco, Catania, Italy.
38 Hematology Department, Institut Catalá d' Oncologia-Hospitalet, Barcelona, Spain.
39 IDIBELL-Institut Catalá d' Oncologia, l'Hospitalet de Llobregat, El Prat de Llobregat, Spain.
40 Section of Bone Marrow Transplant and Cell Therapy, Rush University Medical Center, Chicago, IL, USA.
41 Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
42 Centre for Clinical Research Sormland, Uppsala University, Uppsala, Sweden.
43 Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
44 Blood and Marrow Transplant Program, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
45 Division of Hematology, Ohio State University, Columbus, OH, USA.
46 Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan.
47 Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, USA.
48 The Blood and Marrow Transplant Group of Georgia, Northside Hospital, Atlanta, GA, USA.
49 Department of Hematology/Oncology, Isala Clinic, Zwolle, the Netherlands.
50 Bone Marrow Transplant Program, Penn State Cancer Institute, Hershey, PA, USA.
51 Blood & Marrow Transplantation Program, Division of Hematology/Oncology, Department of Medicine, Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD, USA.
52 Division of Hematology and Transplant Center, Mayo Clinic Rochester, Rochester, MN, USA.
53 Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
54 Laboratory of Myeloid Malignancies, National Heart, Lung, and Blood Institute National Institutes of Health, Bethesda, MD, USA.